Skip to main content

8-K

Pulmatrix, Inc. (PULM)

8-K 2021-04-05 For: 2021-04-02
View Original
Added on April 08, 2026

UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

WASHINGTON,D.C. 20549


FORM8-K



CURRENTREPORT

Pursuantto Section 13 or 15(d) of the

SecuritiesExchange Act of 1934


Dateof Report (Date of earliest event reported): April 2, 2021



PULMATRIX,INC. ****

(Exactname of registrant as specified in its charter)



Delaware 001-36199 46-1821392
(State or other jurisdiction<br><br> <br>of incorporation) (Commission<br><br> <br>File Number) (IRS Employer<br><br> <br>Identification No.)

99Hayden Avenue, Suite 390

Lexington,MA 02421

(Addressof principal executive offices) (Zip Code)


(781)357-2333

(Registrant’stelephone number, including area code)

N/A

(Formername or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ] Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ] Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ] Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ] Pre-commencement<br> communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Nameof exchange on which registered
Common Stock, par value $0.0001 per share PULM The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 2, 2021, Amit D. Munshi resigned from the board of directors of Pulmatrix, Inc. Mr. Munshi’s resignation was not the result of any disagreement regarding any matter relating to the Company’s operations, policies, or practices.

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PULMATRIX, INC.
Date:<br> April 5, 2021 By: /s/ Teofilo Raad
Teofilo<br> Raad
Chief<br> Executive Officer